electroCore, Inc. Common Stock
Veridion Score
Composite trend over time
Why is ECOR moving today?
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ECOR.
ECOR insider activity
electroCore, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net selling: -$235K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 2026-04-23 | Goldberger Daniel S | Insider | sell | $6.80 | 80,000 | 211,471 | $544K | SEC Form 4 |
| 2026-05-29 | 2026-05-28 | Lev Joshua S. | Insider | sell | $9.00 | 6,667 | 84,889 | $60K | SEC Form 4 |
| 2026-05-26 | 2026-05-21 | Errico Thomas J. | Insider | buy | $5.99 | 9,992 | 360,071 | $60K | SEC Form 4 |
| 2026-05-26 | 2026-05-20 | Errico Thomas J. | Insider | buy | $5.98 | 8 | 350,079 | $48 | SEC Form 4 |
| 2026-05-22 | 2026-05-22 | Lev Joshua S. | Insider | sell | $6.50 | 3,000 | 91,556 | $20K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 9 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moECOR contract awards, year to date.
Public federal awards linked to this ticker.
ECOR lobbying filings, year to date.
Registered lobbying filings matched to electroCore, Inc. Common Stock.